Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04751383
Title Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304 United States Details
UCSF Medical Center-Mission Bay San Francisco California 94158 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston Texas 77030 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
British Columbia Children's Hospital Vancouver British Columbia V6H 3V4 Canada Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field